Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

NCT05292664

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, +28 more
Locations
  • University of California San Francisco-Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital Atlanta, Georgia, United States
  • Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

NCT05607108

Conditions
Disease Attributes, Neoplasm Metastasis, Neoplasms, +5 more
Locations
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

68Ga-PSMA PET in the Renal Cell Carcinoma

NCT04987086

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +15 more
Locations
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
  • General Hospital of Ningxia Medical University Yinchuan, Ningxia, China
  • Qinghai University Affiliated Hospital Xining, Qinghai, China
  • Xijing Hospital Xi'an, Shaan'xi, China
View Trial Details
Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

NCT04333706

Conditions
Breast, Cancer, Disseminated Tumor Cell, +7 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Gainesville, Florida, United States
View Trial Details

Related conditions